PROACT 2.0: A new open-source tool to improve patient-doctor communication in clinical trials.

ABSTRACT: The use of Digital Healthcare Products is leading to significant improvements in clinical practice. Herein, we discuss the development of PROACT 2.0 (Patient Reported Opinions About Clinical Tolerability v2.0), a novel open-source mobile and web application developed at Fondazione IRCCS Istituto Nazionale Tumori in Milan. It was developed in collaboration with The Christie, Manchester, in the context of work package 2 of the UpSMART Accelerator project, involving a consortium of referral cancer centers from the UK, Spain and Italy. PROACT 2.0 enhances communication between patients and healthcare providers in cancer clinical trials, allowing patients to report adverse events and side effects, and healthcare teams to collect valuable patient-reported outcome measures for treatment managemen

SUBMITTER: Agnelli L 

PROVIDER: S-EPMC11487894 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature